Carpe diem: Intraday tactics for Dax and Dow

Last post today - hit tight SL on first pull back sell, got +35 on next PB sell .....rinse and repeat

Edit: Closed last short (rinse & repeat) at S1 for +24.....note the 1m doji

Closed all. 10740 seems to be last chance for bulls to pull this back.
I think at end of the day, we should be breaking it. Hopefully

Divergence on 20 pip renko. Might reverse now.

Pendng order Short 10786 SL -40, TP Open

Well called

Might go back to around 10820-10830 on the 30 minute. If we clear 10850 then we have a reversal I would think. May open another short between 10820-10830

SL - B/E

SL hit

EUR is tanking, now 1.068 against the USD. Dax is moving strong.

Surely thats a little bit backwards... weak Euro = Weak DAX surely ?

It tends to be the opposite

Check em:

So Euro goes to Zero and DAX goes to 50000 ... the economys so fucked lol

DAX end of the year 12'500

The logic is as follows:

A weak EUR, makes German exports cheaper for other nations to consume German products. So manufacturing/exporting companies like VW, BMW, Daimler, Continental, Adidas, etc etc sell more products and raise their revenues / profits. When this happens, share prices go up.

In addition, multinational companies with offshore operations tend to make more money because when they convert their foreign income back to a cheaper EUR then it means they receive more EUR in their pocket also, raising revenues / profits , along with share prices.

Thanks for the detailed explanation mate.. much apreciated.

DAX, Long @ 10'847
(H8 Hammer)

DAX, H8, 2015 November 10
click to enlarge!

waek euro? - the same game like 2012

http://www.ft.com/cms/s/0/9ddc73c8-e...#axzz3r6BryArH

August 12, 2012 1:59 pm
Exporters reap the benefits of weak euro
By Chris Bryant in Frankfurt

The weak euro is boosting the sales and earnings of some of the continents biggest companies, helping offset weak demand from Europes crisis-hit periphery.

Although the effects have so far been partly offset by currency hedges, the biggest winners are set to be multinational companies such as Sanofi with a significant cost base in Europe but a high proportion of sales outside the eurozone. Only about one quarter of Sanofi’s sales are generated in euros.
Jerome Contamine, Sanofi’s chief financial officer, surmised that “if it goes on as it is today, it will have a favourable impact on the reported sales and profit in the coming quarters”.

In addition to pharmaceuticals, German premium carmakers, European chemicals, aerospace and luxury goods makers are among those to profit. In contrast, companies in southern Europe that tend to be more dependant on eurozone export markets have realised fewer benefits, aside from the prospect of a pick-up in tourism.

In contrast, mass market European carmakers such as PSA Peugeot Citroën and General Motors’ Opel unit continue to make losses as they are reliant on European sales.

DAX, Long @ 10'812 (2x)

Long @ 17'664 (3x)